Sitagliptin augments angiotensin II-induced renal vasoconstriction in kidneys from rats with metabolic syndrome-Reference-Cited by-同舟云学术

Sitagliptin augments angiotensin II-induced renal vasoconstriction in kidneys from rats with metabolic syndrome

Published:2010-03-30 Issue:7 Volume:37 Page:689-691
ISSN:0305-1870
Container-title:Clinical and Experimental Pharmacology and Physiology
language:en
Short-container-title:

Author:

Tofovic David S,Bilan Victor P,Jackson Edwin K

Publisher

Wiley

Subject

Physiology (medical),Pharmacology,Physiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1440-1681.2010.05389.x/fullpdf

Reference23 articles.

1. Pancreatic polypeptide-fold peptide receptors and angiotensin II-induced renal vasoconstriction;Dubinion;Hypertension,2006

2. Role of renal sympathetic nerves in regulating renovascular responses to angiotensin II in spontaneously hypertensive rats;Dubinion;J. Pharmacol. Exp. Ther.,2006

3. Recent developments in our understanding of the physiological role of PP-fold peptide receptor subtypes;Berglund;Exp. Biol. Med.,2003

4. Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders;Gorrell;Clin. Sci.,2005

5. XVI International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors;Michel;Pharmacol. Rev.,1998

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The protective role of DPP4 inhibitors in atherosclerosis;European Journal of Pharmacology;2020-05

2. More than just an enzyme: Dipeptidyl peptidase-4 (DPP-4) and its association with diabetic kidney remodelling;Pharmacological Research;2019-09

3. Pharmacology of dipeptidyl peptidase-4 inhibitors and its use in the management of metabolic syndrome: a comprehensive review on drug repositioning;DARU Journal of Pharmaceutical Sciences;2019-01-23

4. Renoprotection Provided by Dipeptidyl Peptidase-4 Inhibitors in Combination with Angiotensin Receptor Blockers in Patients with Type 2 Diabetic Nephropathy;Chinese Medical Journal;2018-11-20

5. Renal outcomes with dipeptidyl peptidase-4 inhibitors;Diabetes & Metabolism;2018-03